Journal of Endocrinological Investigation

, Volume 1, Issue 4, pp 299–304 | Cite as

An in vitro procedure for the estimation of thyroid hormone releasing factors in sera of thyrotoxic patients

  • M. L. Maayan
  • E. M. Volpert
  • F. P. Dawry


LATS containing sera and a number of Graves’ disease sera stimulated T4 release from mouse thyroids in vitro as, determined by RIA, thus confirming the presence of a thyroid hormone releasing factor in sera of thyrotoxic patients. The pattern of stimulation was similar to that previously shown for TSH in terms of T4 release time sequence, cAMP increase and catecholamine inhibition via or-adrenergic receptors. In the same in vitro system, neutralization with a human thyroid homogenate showed presence of LATS-Protector (LPA) in LATS negative thyrotoxic sera. The present study describes a simpler procedure for estimating LATS or similar activity, as compared to the McKenzie assay, and suggests identical receptor sites for TSH and other thyroid stimulators.


T4 thyroid hormones LATS Graves’ disease thyrotoxicosis thyroid stimulating immunoglobulins LATS protector 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McKenzie J.M. Long acting thyroid stimulator of Graves’ disease. In: Greer M.A. and Solomon D.H., (Eds), Handbook of Physiology, Endocrinology III. The Thyroid. Am. Physiol. Soc. Wash., D.C., p. 285, 1974.Google Scholar
  2. 2.
    Gafni M., Sirkis N., Gross J. Inhibition of the response of mouse thyroid to thyrotropin induced by chronic triiodothyronine treatment. Endocrinology 97: 1256, 1975.PubMedCrossRefGoogle Scholar
  3. 3.
    Brown J., Munro D.S. A new in vitro assay for thyroid stimulating hormone. J. Endocrinol. 38: 439, 1967.PubMedCrossRefGoogle Scholar
  4. 4.
    Williams JA, Wolff J. Thyroid secretion in vitro: multiple actions of agents affecting secretion. Endocrinology 88: 206, 1971.PubMedCrossRefGoogle Scholar
  5. 5.
    Maayan M.L., Debons A.F., Krimsky I., Volpert E.M., From A., Dawry F., Siclari E. Inhibition of thyrotropin and dibutyryl cyclic AMP induced secretion of thyroxine and triiodothyronine by catecholamines. Endocrinology 101: 284, 1977.PubMedCrossRefGoogle Scholar
  6. 6.
    Adams D.D., Kennedy T.H. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland. J. Clin. Endocrinol. Metab. 27: 173, 1970.CrossRefGoogle Scholar
  7. 7.
    Solomon D.H., Chopra I.J., Chopra V., Smith F.J. Identification of sub-groups of euthyroid Graves’ ophthalmopathy. N. Engl. J. Med. 296: 181, 1977.PubMedCrossRefGoogle Scholar
  8. 8.
    Knox A.J.S., VonWestarp C., Row V.V., Volpé R. Thyroid antigen stimulates lymphocytes from patients with Graves’ disease to produce thyroid stimulating immunoglobulins. J. Clin. Endocrinol. Metab. 43: 330, 1976.PubMedCrossRefGoogle Scholar
  9. 9.
    Volpert E.M. Iodoamino acids in normal and iodine-deficient rat thyroids; comparison between 125l and 127l distribution. Endocrinology 93: 1241, 1973.PubMedCrossRefGoogle Scholar
  10. 10.
    Wood L.C., Burger A., Peterson M., Ingbar S.H. Induction of a LATS-like response by thyroglobulin in the McKenzie assay system. Endocrinology 92: 1538, 1973.PubMedCrossRefGoogle Scholar
  11. 11.
    Wolff J., Cook G.H. Charge effects in the activation of adenylate cyclase. J. Biol. Chem. 250: 6897, 1975.PubMedGoogle Scholar
  12. 12.
    Hall R., Smith B.R., Mukhtar E.D. Thyroid stimulators in health and disease. Clin. Endocrinol. (Oxf.) 4: 213, 1975.CrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1978

Authors and Affiliations

  • M. L. Maayan
    • 1
    • 2
  • E. M. Volpert
    • 1
    • 2
  • F. P. Dawry
    • 1
    • 2
  1. 1.Nuclear Medicine ServiceVeterans Administration HospitalBrooklynUSA
  2. 2.Downstate Medical CenterState University of New YorkBrooklynUSA

Personalised recommendations